Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Osteoarthritis and Cartilage
|
May 31, 2019
Gut microbiota and obesity-associated osteoarthritis
Y Liu, W Ding, H L Wang, et al.
Cell Proliferation
|
March 16, 2011
Influence of proline-rich inositol polyphosphate 5-phosphatase, on early development of fertilized mouse eggs, via inhibition of phosphorylation of Akt
X Deng, C Feng, E-H Wang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
September 10, 2003
[Photoluminescence from Er-doped silicon-rich silicon oxide film and Er-doped silicon-rich silicon nitride film and its annealing behavior]
F C Yuan, G Z Ran, Y Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 7, 2024
[Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax]
J Zhang, B Q Song, X Kong, et al.
The Journal of Clinical Investigation
|
July 4, 2001
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
J K Kim, A Zisman, J J Fillmore, et al.
Leukemia
|
December 17, 2015
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
H Zong, S Sen, G Zhang, et al.
Oncogene
|
August 30, 2011
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
T Papagiannakopoulos, D Friedmann-Morvinski, P Neveu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 17, 2021
[Efficacy and safety of venetoclax and azacitidine in the treatment of refractory and relapsed acute myeloid leukemia]
L H Zong, X X Wu, J Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 7, 2023
[Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia]
J Y Kong, L H Zong, Y Pu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Osteoarthritis and Cartilage
|
May 31, 2019
Gut microbiota and obesity-associated osteoarthritis
Y Liu, W Ding, H L Wang, et al.
Cell Proliferation
|
March 16, 2011
Influence of proline-rich inositol polyphosphate 5-phosphatase, on early development of fertilized mouse eggs, via inhibition of phosphorylation of Akt
X Deng, C Feng, E-H Wang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
September 10, 2003
[Photoluminescence from Er-doped silicon-rich silicon oxide film and Er-doped silicon-rich silicon nitride film and its annealing behavior]
F C Yuan, G Z Ran, Y Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 7, 2024
[Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax]
J Zhang, B Q Song, X Kong, et al.
The Journal of Clinical Investigation
|
July 4, 2001
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
J K Kim, A Zisman, J J Fillmore, et al.
Leukemia
|
December 17, 2015
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
H Zong, S Sen, G Zhang, et al.
Oncogene
|
August 30, 2011
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
T Papagiannakopoulos, D Friedmann-Morvinski, P Neveu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 17, 2021
[Efficacy and safety of venetoclax and azacitidine in the treatment of refractory and relapsed acute myeloid leukemia]
L H Zong, X X Wu, J Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 7, 2023
[Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia]
J Y Kong, L H Zong, Y Pu, et al.
Page
of 5